Clinical Trials Sponsored by Wuhan Optics Valley Vcanbiopharma Co., Ltd.

Total 4 results

Wuhan Optics Valley Vcanbiopharma Co., Ltd.

Recruiting

Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary Fibrosis (IPF) (DEVIF-I)

Idiopathic Pulmonary Fibrosis

China
Wuhan Central Hospital
Wuhan Optics Valley Zhongyuan Pharmaceutical Co., Ltd., Hubei, China; Wuhan...

Recruiting

Treatment With Human Umbilical Cord Mesenchymal Stem Cells for Refractory Diabetic Peripheral Neuropathy

Diabetic Peripheral Neuropathy Type 2

China
Beijing 302 Hospital
Wuhan Optics Valley Zhongyuan Pharmaceutical Co., Ltd., Hubei, China

Not yet recruiting

Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1b)

Decompensated Cirrhosis

China
Renmin Hospital of Wuhan University
VCANBIO Cell & Gene Engineering Corporation, Ltd; Wuhan Optics Valley Zhongyuan...

Recruiting

Study of Human Umbilical Cord Mesenchymal Stem Cell in Patients With Cirrhosis Due to Hepatitis B (Compensation Stage)

Cirrhosis Due to Hepatitis B

China

3

Subscribe